Abstract
OA-41 Iberdomide, bortezomib, and dexamethasone (IberVd) in transplant-ineligible newly diagnosed multiple myeloma (NDMM): results from the CC-220-MM-001 trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have